跳至主要内容
临床试验/JPRN-jRCT2080220558
JPRN-jRCT2080220558未知3 期

A Multi-Center, Open-Labeled Study of Adalimumab in Japanese Subjects with Active Ankylosing Spondylitis

Abbott Japan Co., Ltd.0 个研究点目标入组 30 人开始时间: 2008年5月19日最近更新:
适应症

试验速览

阶段
3 期
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 15age old 至 ot applicable(—)
性别
All

入选标准

  • Subject who meets the definition of Ankylosing Spondylitis based on the Modified New York Criteria
  • - Subject has a diagnosis of active Ankylosing Spondylitis
  • - Subject has had an inadequate response to or intolerance to one or more nonsteroidal anti-inflammatory drugs

排除标准

  • - History of cancer, lymphoma, leukemia or lymphoproliferative disease, active TB, HIV
  • - Previously received anti-TNF therapy
  • - Spinal surgery or joint surgery involving to be assessed within 2 months prior to the Screening

研究者

发起方
Abbott Japan Co., Ltd.

相似试验